These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35399214)
21. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028. Kim H; Yoon YJ; Kim H; Kang S; Cheon HG; Yoo SE; Shin JG; Liu KH Toxicol Lett; 2006 Oct; 166(2):105-14. PubMed ID: 16857327 [TBL] [Abstract][Full Text] [Related]
22. Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes. Jang GR; Wrighton SA; Benet LZ Biochem Pharmacol; 1996 Sep; 52(5):753-61. PubMed ID: 8765473 [TBL] [Abstract][Full Text] [Related]
23. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro. Zeng J; Fan YJ; Tan B; Su HZ; Li Y; Zhang LL; Jiang J; Qiu FR Acta Pharmacol Sin; 2018 Aug; 39(8):1393-1404. PubMed ID: 29417949 [TBL] [Abstract][Full Text] [Related]
24. Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist. Ghosal A; Lu X; Penner N; Gao L; Ramanathan R; Chowdhury SK; Kishnani NS; Alton KB Drug Metab Dispos; 2011 Jan; 39(1):30-8. PubMed ID: 20926621 [TBL] [Abstract][Full Text] [Related]
25. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816 [TBL] [Abstract][Full Text] [Related]
26. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348 [TBL] [Abstract][Full Text] [Related]
27. Identification of cytochrome P450s involved in the metabolism of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1) using human recombinant enzymes and rat liver microsomes in vitro. Lu YY; Cheng HX; Wang X; Wang XW; Liu JY; Li P; Lou YQ; Li J; Lu C; Zhang GL Xenobiotica; 2017 Aug; 47(8):667-672. PubMed ID: 27910729 [TBL] [Abstract][Full Text] [Related]
28. Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. Machinist JM; Mayer MD; Shet MS; Ferrero JL; Rodrigues AD Drug Metab Dispos; 1995 Oct; 23(10):1163-74. PubMed ID: 8654206 [TBL] [Abstract][Full Text] [Related]
29. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein. Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277 [TBL] [Abstract][Full Text] [Related]
30. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6. Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885 [TBL] [Abstract][Full Text] [Related]
31. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro. Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4. Renwick AB; Lewis DF; Fulford S; Surry D; Williams B; Worboys PD; Cai X; Wang RW; Price RJ; Lake BG; Evans DC Xenobiotica; 2001 Apr; 31(4):187-204. PubMed ID: 11465405 [TBL] [Abstract][Full Text] [Related]
34. Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes. Kobayashi K; Chiba K; Yagi T; Shimada N; Taniguchi T; Horie T; Tani M; Yamamoto T; Ishizaki T; Kuroiwa Y J Pharmacol Exp Ther; 1997 Feb; 280(2):927-33. PubMed ID: 9023308 [TBL] [Abstract][Full Text] [Related]
35. Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry. Li Y; Zhang Y; Wang R; Wei L; Deng Y; Ren W J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1052():91-102. PubMed ID: 28376352 [TBL] [Abstract][Full Text] [Related]
36. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179 [TBL] [Abstract][Full Text] [Related]
37. Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Subrahmanyam V; Renwick AB; Walters DG; Price RJ; Tonelli AP; Lake BG Xenobiotica; 2002 Jun; 32(6):521-34. PubMed ID: 12160484 [TBL] [Abstract][Full Text] [Related]